<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067625</url>
  </required_header>
  <id_info>
    <org_study_id>TR-0009 Rev F</org_study_id>
    <nct_id>NCT01067625</nct_id>
  </id_info>
  <brief_title>Endoscopic Bariatric Stapling Pilot Study</brief_title>
  <acronym>TOGA®</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Satiety, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Satiety, Inc.</source>
  <brief_summary>
    <textblock>
      This study is a prospective single-arm, multicenter study to evaluate the safety and
      effectiveness of the TOGA® Procedure for the treatment of morbid obesity.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>February 2006</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent excess weight loss (%EWL)</measure>
    <time_frame>up to 60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events, including serious adverse events, will be recorded to determine safety</measure>
    <time_frame>up to 60 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in Co-morbidities</measure>
    <time_frame>up to 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvements in other Obesity Measures and Change in Quality Of Life Measures</measure>
    <time_frame>up to 60 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>TOGA subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TOGA® System</intervention_name>
    <description>Formation of restrictive sleeve via transoral gastric stapling for treatment of obesity</description>
    <arm_group_label>TOGA subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years - 60 years

          2. Eligible for bariatric surgery per US National Institute of Health (NIH) guidelines
             BMI ≥ 40 kg/m2 and &lt; 55 kg/m2, or BMI ≥ 35 kg/m2 with one or more comorbidities.
             Comorbidities are defined as diabetes, pulmonary disease, cardiac disease, or
             hypertension [systolic blood pressure of ≥140 mm Hg or diastolic blood pressure ≥ 90
             mm Hg (or both) or on treatment for hypertension]

          3. History of obesity for at least 2.5 years

          4. History of failure with non-surgical weight loss methods.

          5. Agree to comply with the substantial dietary restrictions required by the procedure.

          6. Understands risks of procedures, agree to follow protocol requirements, including
             signing informed consent, returning for follow-up visits and completing all required
             testing, completing diet and behavior modification counseling.

        Exclusion Criteria:

          1. Patient history of inflammatory disease of the gastrointestinal tract including
             Crohn's disease or ulcerative colitis.

          2. Significant known esophageal disease including grade 3-4 esophagitis, stricture,
             Barrett's esophagus, esophageal cancer, esophageal diverticulum, nutcracker esophagus,
             achalasia, esophageal dysmotility.

          3. Severe coagulopathy, upper GI bleeding conditions such as esophageal or gastric
             varices, congenital or acquired telangiectasia.

          4. Congenital or acquired anomalies of the GI tract such as atresias or stenoses.

          5. Hiatal hernia ≥2cm

          6. Severe cardiopulmonary disease or other serious organic disease including HIV or
             cancer.

          7. Currently pregnant or nursing. Potentially childbearing (i.e not post-menopausal or
             surgically sterilized) and not willing to use an effective method of contraception for
             the next 12 months.

          8. Current alcohol or drug addiction.

          9. Mentally retarded or emotionally unstable, or exhibits psychological characteristics
             which, in the opinion of the investigator or psychologist/psychiatrist, make the
             subject a poor candidate for this procedure.

         10. Previous gastric, esophageal, pancreatic, or bariatric surgery.

         11. Infection anywhere in the body at the time of the procedure.

         12. Patient history of scleroderma.

         13. Thyroid disease which is not controlled with medication.

         14. Participating in another ongoing clinical trial in which concomitant diagnosis or
             therapeutic intervention would adversely affect the integrity of the clinical trial.

         15. Known active H-pylori infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ULB (Universite Libre de Bruxelles) - Erasme Hospital</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore - Policlinico A. Gemelli</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <last_update_submitted>February 10, 2010</last_update_submitted>
  <last_update_submitted_qc>February 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Allan L. Abati, Ph.D., VP, RA/QA and Clinical Programs</name_title>
    <organization>Satiety, Inc.</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

